Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

A novel method to detect unlabeled inorganic nanoparticles and submicron particles in tissue by sedimentation field-flow fractionation

Cassandra E Deering1 email, Soheyl Tadjiki2 email, Shoeleh Assemi3 email, Jan D Miller3 email, Garold S Yost1 email and John M Veranth1 email

Department of Pharmacology & Toxicology, University of Utah, 30 South 2000 East, Salt Lake City, Utah, USA

Postnova Analytics USA, 230 South 500 East, Suite 150, Salt Lake City, Utah 84103, USA

Department of Metallurgical Engineering, University of Utah, 135 South 1460 East, Salt Lake City, 84112 Utah, USA

author email corresponding author email

Particle and Fibre Toxicology 2008, 5:18doi:10.1186/1743-8977-5-18

Published: 3 December 2008

Abstract

A novel methodology to detect unlabeled inorganic nanoparticles was experimentally demonstrated using a mixture of nano-sized (70 nm) and submicron (250 nm) silicon dioxide particles added to mammalian tissue. The size and concentration of environmentally relevant inorganic particles in a tissue sample can be determined by a procedure consisting of matrix digestion, particle recovery by centrifugation, size separation by sedimentation field-flow fractionation (SdFFF), and detection by light scattering.

Background

Laboratory nanoparticles that have been labeled by fluorescence, radioactivity, or rare elements have provided important information regarding nanoparticle uptake and translocation, but most nanomaterials that are commercially produced for industrial and consumer applications do not contain a specific label.

Methods

Both nitric acid digestion and enzyme digestion were tested with liver and lung tissue as well as with cultured cells. Tissue processing with a mixture of protease enzymes is preferred because it is applicable to a wide range of particle compositions. Samples were visualized via fluorescence microscopy and transmission electron microscopy to validate the SdFFF results. We describe in detail the tissue preparation procedures and discuss method sensitivity compared to reported levels of nanoparticles in vivo.

Conclusion

Tissue digestion and SdFFF complement existing techniques by precisely identifying unlabeled metal oxide nanoparticles and unambiguously distinguishing nanoparticles (diameter<100 nm) from both soluble compounds and from larger particles of the same nominal elemental composition. This is an exciting capability that can facilitate epidemiological and toxicological research on natural and manufactured nanomaterials.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.